查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722879

2025 年至 2033 年抗蛇毒市場規模、佔有率、趨勢及預測（按物種、抗蛇毒類型、作用方式、最終用戶和地區分類）

Anti-venom Market Size, Share, Trends and Forecast by Species, Anti-Venom Type, Mode of Action, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球抗蛇毒市場規模價值 12.401 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 20.597 億美元，2025-2033 年期間的複合年成長率為 5.8%。北美目前佔據市場主導地位，到 2024 年將佔據超過 37.8% 的顯著市場。蛇咬和蝎子螫傷發生率的上升、政府有利舉措的實施以及行業的持續創新是推動市場成長的一些關鍵因素。

抗蛇毒血清，也稱為毒液抗血清，是指用於治療蛇、蜘蛛、蠍子和某些海洋生物（如水母或芋螺）的毒咬或蜇傷的一種藥物。它是透過從犯罪動物中提取毒液，然後將少量毒液注射到馬、羊或山羊等動物體內而獲得的，這些動物的免疫系統會產生抗體，這些抗體被收集和純化以產生抗毒液。抗蛇毒血清可以中和毒素並抵消蛇毒的作用，防止其引起呼吸衰竭或器官損傷等危及生命的併發症。此方法在世界各地被廣泛用於治療毒咬和蜇傷，具體方法取決於病史、檢查以及地理、臨床和病理因素。

抗毒液市場趨勢：

世界各地毒咬和蜇傷案件的增加，特別是在農村和熱帶地區以及農業工人和獵人中，是推動市場成長的主要因素之一。除此之外，消費者對預防蛇咬傷重要性的認知不斷提高，而且產品價格實惠，易於獲得，為市場前景創造了良好的前景。此外，政府為應對蛇咬傷而實施的多項舉措，如教育和培訓計劃，以及對新型抗蛇毒產品研發活動的大量投資，都促進了市場的成長。此外，隨著對動物性蛋白質的需求不斷增加，面臨蛇咬傷風險的牲畜和其他動物的數量也在增加，這反過來又為市場帶來了有利可圖的成長機會。同時，旅行和探索島嶼、沙漠、叢林和狩獵等異國目的地的日益流行，使遊客面臨被蛇咬傷和遭遇其他有毒動物的風險，這是另一個重要的成長誘因。此外，生物技術和醫療保健行業的許多技術進步以及製造技術的持續創新改進，使得生產更有效、更有效率的抗蛇毒產品成為可能，這對市場成長產生了積極影響。除此之外，各種快速蛇毒檢測試劑盒的推出正在推動市場向前發展，這些試劑盒利用快速酶聯免疫吸附試驗，透過從咬傷部位、尿液、血漿、血液或其他組織和體液中採集的樣本來檢測和識別蛇毒。

本報告回答的關鍵問題

  • 什麼是抗蛇毒血清？抗蛇毒市場有多大？
  • 2025 年至 2033 年期間全球抗蛇毒市場預期成長率為何？
  • 推動全球抗蛇毒市場發展的關鍵因素有哪些？
  • 根據物種分類，全球抗蛇毒市場的主要細分市場是什麼？
  • 根據抗蛇毒類型，全球抗蛇毒市場的主要細分市場是什麼？
  • 根據作用方式，全球抗蛇毒市場的主要部分是什麼？
  • 根據最終用戶來看，全球抗蛇毒市場的主要細分市場是什麼？
  • 全球抗蛇毒市場的主要區域有哪些？
  • 全球抗蛇毒市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球抗蛇毒市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依物種

  • 蛇
  • 蠍
  • 蜘蛛
  • 其他

第7章：市場區隔：依抗毒類型

  • 多價抗蛇毒血清
  • 單價抗蛇毒血清

第8章：市場區隔：依行動模式

  • 細胞毒性
  • 神經毒性
  • 血液毒性
  • 心臟毒性
  • 肌肉毒性
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 診所
  • 門診手術中心

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bharat Serums and Vaccines Limited (BSV)
    • Boehringer Ingelheim International GmbH
    • Boston Scientific Corporation
    • CSL Limited
    • Haffkine Bio-Pharmaceutical Corporation Limited
    • Incepta Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Merck KGaA
    • MicroPharm Limited
    • Pfizer Inc.
    • Rare Disease Therapeutics Inc.
Product Code: SR112025A5147

The global anti-venom market size was valued at USD 1,240.1 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,059.7 Million by 2033, exhibiting a CAGR of 5.8% during 2025-2033. North America currently dominates the market, holding a significant market share of over 37.8% in 2024. The rising incidences of snake bites and scorpion stings, the implementation of favorable government initiatives, and ongoing innovations in the industry represent some of the key factors driving the market toward growth.

Anti-venom, also known as venom antiserum, refers to a type of medication used to treat the effects of venomous bites or stings from animals, including snakes, spiders, scorpions, and certain marine creatures such as jellyfish or cone snails. It is obtained by extracting venom from the offending animal and then injecting small amounts of the venom into animals, such as horses, sheep, or goats, whose immune systems produce antibodies that are harvested and purified to create anti-venom. Anti-venom neutralizes the toxins and counteracts the effects of the venom, preventing them from causing life-threatening complications such as respiratory failure or organ damage. It is extensively adopted across the globe in treating venomous bites and stings, depending on their history, examination, and geographic, clinical, and pathologic factors.

Anti-Venom Market Trends:

The rise in cases of venomous bites and stings across the world, particularly in rural and tropical regions and among agricultural workers and hunters, represents one of the prime factors driving the market growth. Besides this, the escalating consumer awareness of the importance of snake bite prevention and easy product availability at an affordable price is creating a favorable outlook for the market. Moreover, the implementation of numerous government initiatives to combat snake bites, such as education and training programs, and intensive investments in research and development (R&D) activities of new anti-venom products are contributing to the market growth. In addition to this, with the rising demand for animal-based protein, there is an increase in the number of livestock and other animals at risk of snake bites, which, in turn, is presenting remunerative growth opportunities for the market. Concurrent with this, the rising popularity of traveling and exploring exotic destinations, such as islands, deserts, jungles, and safaris, that puts tourists at risk of snake bites and other venomous animal encounters is acting as another significant growth-inducing factor. Furthermore, numerous technological advancements in the biotechnology and healthcare industries and ongoing innovative improvements in manufacturing technology, allowing for the production of more effective and efficient anti-venom products, are positively impacting the market growth. Apart from this, the launch of various rapid snake venom detection kits, which utilize a rapid enzyme immunoassay to detect and identify snake venom through samples taken from bite sites, urine, plasma, blood, or other tissues and body fluids, is propelling the market forward.

Key Market Segmentation:

Species Insights:

  • Snake
  • Scorpion
  • Spider
  • Others

Anti-venom Type Insights:

  • Polyvalent Anti-venom
  • Monovalent Anti-venom

Mode of Action Insights:

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

End User Insights:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anti-venom. Some of the factors driving the North America anti-venom market included the increasing incidence of snake bites, the introduction of numerous favorable government initiatives, and the thriving travel and tourism sector.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global anti-venom market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc., and Rare Disease Therapeutics Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What is anti-venom?
  • 2.How big is the anti-venom market?
  • 3.What is the expected growth rate of the global anti-venom market during 2025-2033?
  • 4.What are the key factors driving the global anti-venom market?
  • 5.What is the leading segment of the global anti-venom market based on the species?
  • 6.What is the leading segment of the global anti-venom market based on anti-venom type?
  • 7.What is the leading segment of the global anti-venom market based on the mode of action?
  • 8.What is the leading segment of the global anti-venom market based on the end user?
  • 9.What are the key regions in the global anti-venom market?
  • 10.Who are the key players/companies in the global anti-venom market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-venom Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Species

  • 6.1 Snake
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Scorpion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Spider
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Anti-venom Type

  • 7.1 Polyvalent Anti-venom
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Monovalent Anti-venom
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Action

  • 8.1 Cytotoxic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Neurotoxic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Haemotoxic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiotoxic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Myotoxic
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bharat Serums and Vaccines Limited (BSV)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Haffkine Bio-Pharmaceutical Corporation Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Incepta Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MicroPharm Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Rare Disease Therapeutics Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-venom Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2024
  • Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2024
  • Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2024
  • Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Anti-venom Industry: SWOT Analysis
  • Figure 89: Global: Anti-venom Industry: Value Chain Analysis
  • Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-venom Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million USD), 2025-2033
  • Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million USD), 2025-2033
  • Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million USD), 2025-2033
  • Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Anti-venom Market: Competitive Structure
  • Table 8: Global: Anti-venom Market: Key Players